Literature DB >> 28481693

Immunotherapy of mold allergy: A review.

A Bozek1, K Pyrkosz1.   

Abstract

Mold allergies are common, mainly target the respiratory tract and present as allergic rhinitis and/or bronchial asthma. Molds include a large group of different allergens that induce all types of allergic reactions. Allergen specific immunotherapies (AITs) to molds are common; however, at the present time, they are limited to Alternaria. This review presents not only the benefits but also the problems with such types of AIT based on the literature and our experience.

Entities:  

Keywords:  Alternaria; Cladosporium; IgE; immunotherapy; mold

Mesh：

Substances：

Year:  2017        PMID： 28481693      PMCID： PMC5647975          DOI： 10.1080/21645515.2017.1314404

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


  53 in total

1.  Mold allergy. Introduction.

Authors:  L Aukrust
Journal:  Clin Rev Allergy       Date:  1992

Review 2.  Indoor fungal diversity and asthma: a meta-analysis and systematic review of risk factors.

Authors:  Richard A Sharpe; Nick Bearman; Christopher R Thornton; Kerryn Husk; Nicholas J Osborne
Journal:  J Allergy Clin Immunol       Date:  2014-08-23       Impact factor: 10.793

3.  Efficacy of sublingual specific immunotherapy in patients with respiratory allergy to Alternaria alternata: a randomised, assessor-blinded, patient-reported outcome, controlled 3-year trial.

Authors:  Marcella Pozzan; Massimo Milani
Journal:  Curr Med Res Opin       Date:  2010-11-04       Impact factor: 2.580

4.  Stability of standardized grass, dust mite, cat, and short ragweed allergens after mixing with mold or cockroach extracts.

Authors:  Thomas J Grier; Dawn M LeFevre; Elizabeth A Duncan; Robert E Esch
Journal:  Ann Allergy Asthma Immunol       Date:  2007-08       Impact factor: 6.347

5.  Diagnosis and immunotherapy of mould allergy. V. Clinical efficacy and side effects of immunotherapy with Cladosporium herbarum.

Authors:  H J Malling; S Dreborg; B Weeke
Journal:  Allergy       Date:  1986-09       Impact factor: 13.146

6.  Effect of allergen-specific immunotherapy with purified Alt a1 on AMP responsiveness, exhaled nitric oxide and exhaled breath condensate pH: a randomized double blind study.

Authors:  Luis Prieto; Ricardo Palacios; Dulce Aldana; Anna Ferrer; Carmen Perez-Frances; Victoria Lopez; Rocio Rojas
Journal:  Allergy Asthma Clin Immunol       Date:  2010-09-16       Impact factor: 3.406

7.  Diagnosis and immunotherapy of mould allergy. VI. IgE-mediated parameters during a one-year placebo-controlled study of immunotherapy with Cladosporium.

Authors:  H J Malling; S Dreborg; B Weeke
Journal:  Allergy       Date:  1987-05       Impact factor: 13.146

Review 8.  Manufacturing and standardizing fungal allergen products.

Authors:  Robert E Esch
Journal:  J Allergy Clin Immunol       Date:  2004-02       Impact factor: 10.793

9.  The hazard of mould hyposensitization in children with asthma.

Authors:  P H Kaad; P A Ostergaard
Journal:  Clin Allergy       Date:  1982-05

Review 10.  Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project.

Authors:  M A Calderon; P Demoly; T Casale; C A Akdis; C Bachert; M Bewick; B M Bilò; B Bohle; S Bonini; A Bush; D P Caimmi; G W Canonica; V Cardona; A M Chiriac; L Cox; A Custovic; F De Blay; P Devillier; A Didier; G Di Lorenzo; G Du Toit; S R Durham; P Eng; A Fiocchi; A T Fox; R Gerth van Wijk; R M Gomez; T Haathela; S Halken; P W Hellings; L Jacobsen; J Just; L K Tanno; J Kleine-Tebbe; L Klimek; E F Knol; P Kuna; D E Larenas-Linnemann; A Linneberg; M Matricardi; H J Malling; R Moesges; J Mullol; A Muraro; N Papadopoulos; G Passalacqua; E Pastorello; O Pfaar; D Price; P Rodriguez Del Rio; R Ruëff; B Samolinski; G K Scadding; G Senti; M H Shamji; A Sheikh; J C Sisul; D Sole; G J Sturm; A Tabar; R Van Ree; M T Ventura; C Vidal; E M Varga; M Worm; T Zuberbier; J Bousquet
Journal:  Clin Transl Allergy       Date:  2016-11-23       Impact factor: 5.871
View more
  7 in total

1.  Broad perspectives of allergen specific immunotherapy.

Authors:  Wayne Robert Thomas
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

Review 2.  Initiation and Pathogenesis of Severe Asthma with Fungal Sensitization.

Authors:  Meenakshi Tiwary; Amali E Samarasinghe
Journal:  Cells       Date:  2021-04-15       Impact factor: 6.600

3.  Immunotherapy With Recombinant Alt a 1 Suppresses Allergic Asthma and Influences T Follicular Cells and Regulatory B Cells in Mice.

Authors:  Juan Liu; Jia Yin
Journal:  Front Immunol       Date:  2021-11-05       Impact factor: 7.561

4.  Airborne fungal and bacterial microbiome in classrooms of elementary schools during the COVID-19 pandemic period: Effects of school disinfection and other environmental factors.

Authors:  Jun I L Yang; Bong Gu Lee; Ju-Hyeong Park; Min-Kyeong Yeo
Journal:  Indoor Air       Date:  2022-09       Impact factor: 6.554

5.  The Identification and Characterization of Immunoreactive Fungal Proteins Recognized by Sera from Zimbabweans Sensitized to Fungi.

Authors:  Lorraine Tsitsi Pfavayi; Richard Burchmore; Elopy Nimele Sibanda; Stephen Baker; Mark Woolhouse; Takafira Mduluza; Francisca Mutapi
Journal:  Int Arch Allergy Immunol       Date:  2022-05-18       Impact factor: 3.767

Review 6.  The allergenic activity and clinical impact of individual IgE-antibody binding molecules from indoor allergen sources.

Authors:  Luis Caraballo; Rudolf Valenta; Leonardo Puerta; Anna Pomés; Josefina Zakzuk; Enrique Fernandez-Caldas; Nathalie Acevedo; Mario Sanchez-Borges; Ignacio Ansotegui; Luo Zhang; Marianne van Hage; Eva Fernández; Luisa Arruda; Susanne Vrtala; Mirela Curin; Hans Gronlund; Antonina Karsonova; Jonathan Kilimajer; Ksenja Riabova; Daria Trifonova; Alexander Karaulov
Journal:  World Allergy Organ J       Date:  2020-04-29       Impact factor: 4.084

Review 7.  Allergen Immunotherapy: Current and Future Trends.

Authors:  Gandhi F Pavón-Romero; Maria Itzel Parra-Vargas; Fernando Ramírez-Jiménez; Esmeralda Melgoza-Ruiz; Nancy H Serrano-Pérez; Luis M Teran
Journal:  Cells       Date:  2022-01-08       Impact factor: 6.600
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.